The checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a new global study led by Yale Cancer Center (YCC). The data was published today in the journal The Lancet.
The...
Eve Ensler, the Tony Award-winning playwright of “The Vagina Monologues,” says humans have a superpower so great it can conjure the dead and burn away cancer: It’s our imagination.
Ten years ago, when she was diagnosed with stage-three uterine cancer,...
Scientists have looked for immune system factors that might help mosquitoes ward off pathogens such as malarial parasites and indirectly protect humans from infection. Yale researchers found one by editing a single gene, which turns out to be crucial for...
For those with extremely high blood pressure, or hypertension, there are many initial medication options — so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and...
Age-related macular degeneration is one of the leading causes of blindness in the elderly, affecting more than 2 million people in the United States and leading to progressive loss of central vision. Genome wide studies have identified almost three dozen...
Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has...
The lab of Stephen Waxman, Bridget M. Flaherty Professor of Neurology and of neuroscience, has identified the key role of sodium channels arrayed on nerve cells in experience of pain.
In a new paper published in Science Advances, the Yale team led by...